Cellular Cholesterol Regulates Ubiquitination and Degradation of the Cholesterol Export Proteins ABCA1 and ABCG1

被引:62
|
作者
Hsieh, Victar [5 ]
Kim, Mi-Jurng [5 ]
Gelissen, Ingrid C. [3 ]
Brown, Andrew J. [4 ]
Sandoval, Cecilia [5 ]
Hallab, Jeannette C. [5 ]
Kockx, Maaike [1 ]
Traini, Mathew [1 ]
Jessup, Wendy [1 ]
Kritharides, Leonard [1 ,2 ]
机构
[1] Concord Hosp, ANZAC Res Inst, Atherosclerosis Lab, Concord, NSW 2139, Australia
[2] Concord Hosp, Dept Cardiol, Concord, NSW 2139, Australia
[3] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[4] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia
[5] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia
基金
英国医学研究理事会;
关键词
ABC Transporter; Cholesterol; Proteasome; Protein Degradation; Ubiquitination; ABCA1; ABCG1; CASSETTE TRANSPORTER A1; ATHEROSCLEROTIC LESION DEVELOPMENT; DENSITY-LIPOPROTEIN RECEPTOR; LDL RECEPTOR; HELICAL APOLIPOPROTEINS; LYSOSOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; LOADED MACROPHAGES; PROTEASOME PATHWAY; FOAM CELLS;
D O I
10.1074/jbc.M113.515890
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Cholesterol transporters ABCA1 and ABCG1 export excess cellular cholesterol and protect against atherosclerosis. Results: Cholesterol loading decreases cellular degradation of ABCA1 and ABCG1 and also their ubiquitination. Conclusion: Cholesterol-dependent suppression of ABCA1 and ABCG1 ubiquitination decreases their proteasomal degradation. Significance: This mechanism enhances the capacity of cholesterol-loaded cells to export their excess cholesterol. The objective of this study was to examine the influence of cholesterol in post-translational control of ABCA1 and ABCG1 protein expression. Using CHO cell lines stably expressing human ABCA1 or ABCG1, we observed that the abundance of these proteins is increased by cell cholesterol loading. The response to increased cholesterol is rapid, is independent of transcription, and appears to be specific for these membrane proteins. The effect is mediated through cholesterol-dependent inhibition of transporter protein degradation. Cell cholesterol loading similarly regulates degradation of endogenously expressed ABCA1 and ABCG1 in human THP-1 macrophages. Turnover of ABCA1 and ABCG1 is strongly inhibited by proteasomal inhibitors and is unresponsive to inhibitors of lysosomal proteolysis. Furthermore, cell cholesterol loading inhibits ubiquitination of ABCA1 and ABCG1. Our findings provide evidence for a rapid, cholesterol-dependent, post-translational control of ABCA1 and ABCG1 protein levels, mediated through a specific and sterol-sensitive mechanism for suppression of transporter protein ubiquitination, which in turn decreases proteasomal degradation. This provides a mechanism for acute fine-tuning of cholesterol transporter activity in response to fluctuations in cell cholesterol levels, in addition to the longer term cholesterol-dependent transcriptional regulation of these genes.
引用
收藏
页码:7524 / 7536
页数:13
相关论文
共 50 条
  • [21] ABCA1 and ABCG1 or ABCG4 act sequentially to generate large cholesterol-rich HDL particles
    Vaughan, AM
    Oram, JF
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E45 - E46
  • [22] Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity
    Aye, Irving L. M. H.
    Waddell, Brendan J.
    Mark, Peter J.
    Keelan, Jeffrey A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (09): : 1013 - 1024
  • [23] Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
    Wang, Xun
    Collins, Heidi L.
    Ranalletta, Mollie
    Fuki, Ilia V.
    Billheimer, Jeffrey T.
    Rothblat, George H.
    Tall, Alan R.
    Rader, Daniel J.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (08): : 2216 - 2224
  • [24] RELATIONSHIP OF ORPHAN RECEPTOR RORα AND CHOLESTEROL TRANSPORTERS ABCA1 AND ABCG1 EXPRESSION IN VISCERAL ADIPOSE TISSUE
    Miroshnikova, V.
    Panteleeva, A.
    Demina, E.
    Usenko, T.
    Bazhenova, E.
    Semenova, I.
    Berkovich, O.
    Baranova, E.
    Pchelina, S.
    ATHEROSCLEROSIS, 2016, 252 : E130 - E130
  • [25] Rosmarinic Acid Increases Macrophage Cholesterol Efflux through Regulation of ABCA1 and ABCG1 in Different Mechanisms
    Nyandwi, Jean-Baptiste
    Ko, Young Shin
    Jin, Hana
    Yun, Seung Pil
    Park, Sang Won
    Kim, Hye Jung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [26] Mangiferin promotes macrophage cholesterol efflux and protects against atherosclerosis by augmenting the expression of ABCA1 and ABCG1
    Ren, Kun
    Li, Heng
    Zhou, Hui-Fang
    Liang, Yin
    Tong, Min
    Chen, Lu
    Zheng, Xi-Long
    Zhao, Guo-Jun
    AGING-US, 2019, 11 (23): : 10992 - 11009
  • [27] THE INHIBITION OF UBIQUITIN-PROTEASOME-DEPENDENT DEGRADATION OF ABCA1 AND ABCG1 ENHANCES REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VITRO AND IN VIVO
    Ogura, M.
    Ayaori, M.
    Kondo, H.
    Ikewaki, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 86 - 86
  • [28] Human Endothelial Cells of the Placental Barrier Efficiently Deliver Cholesterol to the Fetal Circulation via ABCA1 and ABCG1
    Stefulj, Jasminka
    Panzenboeck, Ute
    Becker, Tatjana
    Hirschmugl, Birgit
    Schweinzer, Cornelia
    Lang, Ingrid
    Marsche, Gunther
    Sadjak, Anton
    Lang, Uwe
    Desoye, Gernot
    Wadsack, Christian
    CIRCULATION RESEARCH, 2009, 104 (05) : 600 - U79
  • [29] Cholesterol Transporters ABCA1 and ABCG1 Gene Expression in Peripheral Blood Mononuclear Cells in Patients with Metabolic Syndrome
    Tavoosi, Zahra
    Moradi-Sardareh, Hemen
    Saidijam, Massoud
    Yadegarazari, Reza
    Borzuei, Shiva
    Soltanian, Alireza
    Goodarzi, Mohammad Taghi
    CHOLESTEROL, 2015,
  • [30] EFFECT OF CHRONIC RENAL FAILURE ON SERUM AND HDL CHOLESTEROL EFFLUX CAPACITY AND MACROPHAGE ABCA1/ABCG1 EXPRESSION
    Schreier, S.
    Hollaus, M.
    Pemberger, E.
    Fruhwuerth, S.
    Roehrl, C.
    Liebscher, F.
    Englinger, B.
    Becker, J.
    Schmidt, A.
    Scharnagl, H.
    Aufricht, C.
    Stangl, H.
    Strobl, W.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 45 - 46